Use for the qualitative detection of IgG antibodies against the nucleocapsid protein of SARS-CoV-2 (COVID-19) to evaluate exposure. To reduce the likelihood of a false-positive result, the CDC Interim Guidelines for COVID-19 Antibody Testing suggest using an orthogonal testing algorithm so that individuals positive by one antibody test are retested with a second antibody test (refer to COVID-19 IgG by ELISA 3002723).
Qualitative Chemiluminescent Immunoassay
Serum separator tube (SST) or EDTA plasma
Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 0.5mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.25 mL)
Grossly hemolyzed, grossly icteric, or severely lipemic specimens.
Preferred: ARUP Standard Transport Tube for specimen submission (ARUP Item# 15824).
Refrigerated: 1 week; Frozen: 1 month
The COVID-19 IgG, Qualitative by CIA test is for in vitro diagnostic use under an FDA Emergency Use Authorization (EUA). In compliance with this authorization, please visit https://www.aruplab.com/infectious-disease/coronavirus/testing for more information and to access the applicable information sheets. This test should not be used for screening of donated blood.
No compliance statements are in use for this test.
|Component Test Code*||Component Chart Name||LOINC|
|3002777||COVID-19 IgG, Qualitative||94507-1|
- Coronavirus Disease - 2019
- COVID-19 Illness
- COVID19 IgG Ab